Clinical Oncology Next Generation Sequencing (NGS) Market Studies Research Report 2025
The global market for clinical oncology next generation sequencing is expected to be benefitted by the growing use of advanced genetic sequencing analysis in several fields of clinical research owing to the simultaneous fall in the costs of base pair mapping and is likely to render high impact on the market over the coming years.
View full press release